Axel Wester

952 total citations · 1 hit paper
37 papers, 379 citations indexed

About

Axel Wester is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Axel Wester has authored 37 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Axel Wester's work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (14 papers) and Alcohol Consumption and Health Effects (6 papers). Axel Wester is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (14 papers) and Alcohol Consumption and Health Effects (6 papers). Axel Wester collaborates with scholars based in Sweden, United States and Denmark. Axel Wester's co-authors include Hannes Hagström, Ying Shang, Linnea Widman, Sasha Koul, Pontus Andell, Patrik Nasr, David Erlinge, Moman A. Mohammad, Stergios Kechagias and Anthony Matthews and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Gut.

In The Last Decade

Axel Wester

35 papers receiving 378 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

2024 36 citations Axel Wester, Ying Shang et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Wester Sweden	12	210	108	107	99	91	37	379
Min-Kyung Kim South Korea	12	89 0.4×	26 0.2×	74 0.7×	42 0.4×	118 1.3×	14	352
Giuseppe Repetto Brazil	8	263 1.3×	95 0.9×	216 2.0×	151 1.5×	51 0.6×	12	488
Kristine Alexander United States	9	89 0.4×	29 0.3×	61 0.6×	51 0.5×	60 0.7×	14	289
Chung-Bao Hsieh Taiwan	9	38 0.2×	67 0.6×	192 1.8×	102 1.0×	41 0.5×	28	328
Theodore Gleason United States	5	260 1.2×	118 1.1×	97 0.9×	177 1.8×	42 0.5×	5	436
Akira Tsuneto Japan	10	121 0.6×	20 0.2×	108 1.0×	39 0.4×	342 3.8×	35	440
Murillo Pimentel Utrini Brazil	13	167 0.8×	36 0.3×	256 2.4×	83 0.8×	53 0.6×	34	399
Pedro Benito López Spain	8	74 0.4×	95 0.9×	180 1.7×	121 1.2×	25 0.3×	22	347
Martinho Antônio Gestic Brazil	13	178 0.8×	40 0.4×	286 2.7×	85 0.9×	54 0.6×	48	437
Naruto Horiuchi Japan	12	157 0.7×	39 0.4×	148 1.4×	180 1.8×	67 0.7×	22	480

Countries citing papers authored by Axel Wester

Since Specialization

Citations

This map shows the geographic impact of Axel Wester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Wester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Wester more than expected).

Fields of papers citing papers by Axel Wester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Wester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Wester. The network helps show where Axel Wester may publish in the future.

Co-authorship network of co-authors of Axel Wester

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Wester. A scholar is included among the top collaborators of Axel Wester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Wester. Axel Wester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boeckmans, Joost, et al.. (2025). Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case–control study in Sweden. BMJ Public Health. 3(2). e003322–e003322.

Vaz, Juan, Patrik Nasr, Anders Helander, et al.. (2025). Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes. Journal of Hepatology. 83(5). 1011–1022. 7 indexed citations

Shang, Ying, et al.. (2025). Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden. Journal of Hepatology. 83(3). 643–651. 12 indexed citations

Hakansson, A., Sasha Koul, Elmir Ömerovic, et al.. (2024). Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association. 13(13). e034709–e034709. 3 indexed citations

Nasr, Patrik, Axel Wester, Mattias Ekstedt, et al.. (2024). Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis. Clinical Gastroenterology and Hepatology. 22(5). 1048–1057.e2. 34 indexed citations

Widman, Linnea, et al.. (2024). Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients. Alimentary Pharmacology & Therapeutics. 61(1). 109–121. 1 indexed citations

Nasr, Patrik, Ying Shang, Axel Wester, et al.. (2024). Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction‐associated steatotic liver disease. Liver International. 44(11). 3050–3059. 6 indexed citations

Wester, Axel, et al.. (2024). Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut. 73(5). 835–843. 36 indexed citations breakdown →

Wester, Axel, Soo Aleman, Håkan Ekvall, et al.. (2024). Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients. Liver International. 44(7). 1689–1699. 9 indexed citations

10.

Koul, Sasha, Elmir Ömerovic, John Andersson, et al.. (2023). Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry. European Heart Journal. 44(Supplement_2). 1 indexed citations

11.

Ebrahimi, Fahim, Tracey G. Simon, Hannes Hagström, et al.. (2023). Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study. Clinical Gastroenterology and Hepatology. 21(13). 3346–3355.e19. 15 indexed citations

12.

Wester, Axel, et al.. (2023). Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients. Scandinavian Journal of Gastroenterology. 58(8). 931–936. 19 indexed citations

13.

Shang, Ying, Qing Shen, Elliot B. Tapper, Axel Wester, & Hannes Hagström. (2023). Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study. Hepatology Communications. 7(11). 3 indexed citations

14.

Wester, Axel, Daphne Vassiliou, Ylva Flodérus, et al.. (2023). Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients. Journal of Inherited Metabolic Disease. 46(6). 1186–1194. 4 indexed citations

15.

Shang, Ying, Linnea Widman, Fahim Ebrahimi, et al.. (2023). Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study. Liver International. 43(10). 2142–2152. 11 indexed citations

16.

Wester, Axel, et al.. (2023). Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study. Journal of Internal Medicine. 294(2). 164–177. 9 indexed citations

17.

Hagström, Hannes, Ying Shang, Elliot B. Tapper, Axel Wester, & Linnea Widman. (2023). Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients. Clinical Gastroenterology and Hepatology. 21(13). 3336–3345.e2. 3 indexed citations

18.

Holmer, Magnus, Mattias Ekstedt, Patrik Nasr, et al.. (2022). Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up. Liver International. 42(12). 2769–2780. 24 indexed citations

19.

Åberg, Fredrik, et al.. (2022). Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study. Clinical Gastroenterology and Hepatology. 21(4). 995–1004.e9. 1 indexed citations

20.

Wester, Axel, Moman A. Mohammad, Pontus Andell, et al.. (2018). Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: A SWEDEHEART study. Resuscitation. 126. 172–178. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact